Back
CytoMed Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
GDTC
Sponsored
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
50
GDTC
CytoMed Therapeutics
Last Price:
1.95
Seasonality Move:
-37.85%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.CytoMed Therapeutics Price Quote
$1.95
-0.22 (-8.02%)
(Updated: November 16, 2024 at 5:19 AM ET)
CytoMed Therapeutics Key Stats
Sell
50
CytoMed Therapeutics (GDTC)
is a Sell
Day range:
$1.83 - $2.52
52-week range:
$1.20 - $5.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.35%
Volume:
10.8K
Avg. volume:
19.4K
1-year change:
-45.78%
Market cap:
$25.1M
Revenue:
$0
EPS:
$-0.19
How Much Does CytoMed Therapeutics Make?
Data Unavailable
Is CytoMed Therapeutics Growing As A Company?
Data Unavailable
CytoMed Therapeutics Stock Price Performance
-
Did CytoMed Therapeutics Stock Go Up Last Month?
CytoMed Therapeutics share price went up by 4.53% last month -
Did GDTC's Share Price Rise Over The Last Year?
GDTC share price fell by -45.78% over the past 1 year
What Is CytoMed Therapeutics 52-Week High & Low?
-
What Is CytoMed Therapeutics’s 52-Week High Share Price?
CytoMed Therapeutics has traded as high as $5.50 over the past 52 weeks -
What Is CytoMed Therapeutics’s 52-Week Low Share Price?
CytoMed Therapeutics has traded as low as $1.20 over the past 52 weeks
CytoMed Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy CytoMed Therapeutics?
-
How Much Debt Does CytoMed Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does CytoMed Therapeutics Have?
Cash and short term investments quarterly total is $4.8M -
What Is CytoMed Therapeutics’s Book Value Per Share?
Book value per share is 0.65
Is CytoMed Therapeutics Cash Flow Positive?
-
What Is GDTC Cash Flow From Operations?
Cash flow from operations (TTM) is -$1.9M -
What Is CytoMed Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$22.2K -
What Is CytoMed Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $554K
CytoMed Therapeutics Return On Invested Capital
Data Unavailable
CytoMed Therapeutics Earnings Date & Stock Price
-
What Is CytoMed Therapeutics's Stock Price Today?
A single share of GDTC can be purchased today for 2.17 -
What Is CytoMed Therapeutics’s Stock Symbol?
CytoMed Therapeutics trades on the nasdaq under the ticker symbol: GDTC -
When Is CytoMed Therapeutics’s Next Earnings Date?
The next quarterly earnings date for CytoMed Therapeutics is scheduled on April 29, 2025 -
When Is GDTC's next ex-dividend date?
CytoMed Therapeutics's next ex-dividend date is November 16, 2024 -
How To Buy CytoMed Therapeutics Stock?
You can buy CytoMed Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
CytoMed Therapeutics Competitors
-
Who Are CytoMed Therapeutics's Competitors?
Below is a list of companies who compete with CytoMed Therapeutics or are related in some way:
CytoMed Therapeutics Dividend Yield
-
What Is GDTC Dividend Yield?
CytoMed Therapeutics’s dividend yield currently is 0% -
What Is CytoMed Therapeutics’s Payout Ratio?
CytoMed Therapeutics’s payout ratio is 0% -
When Did CytoMed Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 16, 2024 -
What Is CytoMed Therapeutics’s Dividend Per Share?
CytoMed Therapeutics pays a dividend of $0.00 per share
CytoMed Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 5.00 |
Upside from Last Price: | 129.96% |